A lung cancer trial bolsters a long-held idea that treatment timing matters, showing a simple shift could help immunotherapy ...

Tarlatamab (Imdelltra) is a new type of immunotherapy approved for people with small-cell lung cancer whose disease has ...

Researchers have identified a biological mechanism that helps explain why some lung and ovarian cancers become resistant to ...

The FDA approved a once-monthly Rybrevant Faspro schedule with Lazcluze for first-line EGFR-mutated advanced NSCLC, reducing ...

A gene therapy that patients breathe in has been found to shrink lung tumours by inserting immune-boosting genes into ...

The FDA has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneous, chemo-free ...

The FDA approved Keytruda for NSCLC based on several clinical trials. Keytruda was studied in people whose NSCLC had spread to other parts of the body (metastatic) and who had received no prior ...

As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity decreases, scans show improvement, and patient lifespans are prolonged for some ...

How Well Does Tagrisso Work for Lung Cancer? The FDA approved Tagrisso based on clinical trials for EGFR-mutated lung cancer in several different scenarios. Tagrisso was studied in people who had lung ...

Vaping poses possible heart, lung and cancer risks, France’s national health agency warned on Wednesday, as it raised ...

We are exposed to air pollution daily. When we step outside, we inhale pollutants from particulate matter (such as smoke or dust), burning fossil fuels, wildfires and more. For Lung Cancer Awareness ...